alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# L_2018090EN.01006101.xml

| 6.4.2018 | EN | Official Journal of the European Union | L 90/61 |
| --- | --- | --- | --- |

6.4.2018

EN

Official Journal of the European Union

L 90/61

---

COMMISSION DELEGATED REGULATION (EU) 2018/542

of 22 January 2018

correcting the Greek language version of Delegated Regulation (EU) 2017/86 establishing a discard plan for certain demersal fisheries in the Mediterranean Sea

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 1380/2013 of the European Parliament and of the Council of 11 December 2013 on the Common Fisheries Policy, amending Council Regulations (EC) No 1954/2003 and (EC) No 1224/2009 and repealing Council Regulations (EC) No 2371/2002 and (EC) No 639/2004 and Council Decision 2004/585/EC (1), and in particular Article 15(6) thereof,

Whereas:

| (1) | The Greek language version of Commission Delegated Regulation (EU) 2017/86 (2) contains an error in Article 4(b)(i), (ii) and (iii), Article 4(c)(i) and (ii), Article 5(2) and in the tables of points 2 and 3 of the Annex as regards the translation of a fish species, thus affecting the scope of various provisions of that Regulation. |
| --- | --- |

(1)

The Greek language version of Commission Delegated Regulation (EU) 2017/86 (2) contains an error in Article 4(b)(i), (ii) and (iii), Article 4(c)(i) and (ii), Article 5(2) and in the tables of points 2 and 3 of the Annex as regards the translation of a fish species, thus affecting the scope of various provisions of that Regulation.

| (2) | The Greek language version of Delegated Regulation (EU) 2017/86 should therefore be corrected accordingly. The other language versions are not affected, |
| --- | --- |

(2)

The Greek language version of Delegated Regulation (EU) 2017/86 should therefore be corrected accordingly. The other language versions are not affected,

HAS ADOPTED THIS REGULATION:

Article 1

(does not concern the English language)

Article 2

This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 22 January 2018.

For the Commission

The President

Jean-Claude JUNCKER

---

(1)  
  OJ L 354, 28.12.2013, p. 22.

1

(2)  Commission Delegated Regulation (EU) 2017/86 of 20 October 2016 establishing a discard plan for certain demersal fisheries in the Mediterranean Sea (OJ L 14, 18.1.2017, p. 4).

2

---
#### § 26.10 Regulatory authorities not listed as currently equivalent.

Authorities not currently listed as equivalent, or not equivalent for certain types of inspections, product classes or processes may apply for reconsideration of their status once the necessary corrective measures have been taken or additional experience is gained.
<PAGE>   1


                                                            THOMAS H. NELSON
                                                             (206) 340-9654
 _________________, 1998                                 tnelson@grahamdunn.com



                                                                     EXHIBIT 8.2

   
Glacier Bancorp, Inc.                                     Valley Bank of Helena
202 Main Street                                           3030 N. Montana Avenue
Kalispell, Montana  59903                                 Helena, Montana  59601
    

        Re: Share Exchange / Tax Consequences

Ladies and Gentlemen:

   
        This letter responds to your request for our opinion as to certain of
the federal income tax consequences of the proposed share exchange ("Share
Exchange") between Glacier Bancorp, Inc. ("Glacier"), a Delaware corporation and
bank holding corporation, and Valley Bank of Helena ("VB"), a Montana
state-chartered commercial bank. Immediately prior to the Share Exchange, HUB
Financial Corporation ("HUB"), a Montana corporation and bank holding company,
proposes to merge with and into Glacier (the "Merger"). Prior to the Merger, HUB
owned approximately 86.5 percent of the issued and outstanding common stock of
VB.
    

        We have acted as legal counsel to Glacier in connection with the Share
Exchange. For the purpose of rendering this opinion, we have examined and relied
upon originals, certified copies, or copies otherwise identified to our
satisfaction as being true copies of the originals of the following documents,
including all exhibits and schedules attached to them:

        (a)     The Plan and Agreement of Merger, dated as of December 30, 1997,
                between Glacier and HUB (the "Merger Agreement");

        (b)     Agreement and Plan of Share Exchange, dated as of December 30,
                1997, between Glacier and VB (the "Plan");

        (c)     Form S-4 Registration Statement of Glacier filed with the
                Securities and Exchange Commission on ____________, 1998;

        (d)     The Proxy Statement of HUB (included as part of the Registration
                Statement);

        (e)     The Proxy Statement of VB (included as part of the Registration
                Statement);

        (f)     The factual representations set forth in a letter from Glacier
                and VB, dated ___________________, 1998; and
§ 346.10 Local anesthetic active ingredients. The active ingredient of the product consists of any of the following when used in the concentration or within the concentration range established for each ingredient: ( a ) Benzocaine 5 to 20 percent.
( b ) Benzyl alcohol 1 to 4 percent.
( c ) Dibucaine 0.25 to 1 percent.
( d ) Dibucaine hydrochloride 0.25 to 1 percent.
( e ) Dyclonine hydrochloride 0.5 to 1 percent.
( f ) Lidocaine 2 to 5 percent.
( g ) Pramoxine hydrochloride 1 percent.
( h ) Tetracaine 0.5 to 1 percent.
( i ) Tetracaine hydrochloride 0.5 to 1 percent.
<PAGE>

                                                                      Exhibit 23

                        Consent of Independent Auditors

We consent to the incorporation by reference in the Registration Statement (Form
S-8 No. 333-51719) pertaining to the Midway Airlines Corporation Executive
Officers Stock Option Agreements and the Midway Airlines Corporation 1997 Stock
Option Plan and in the Registration Statement (Form S-3 No. 333-38244) of our
report dated January 30, 2001, with respect to the consolidated financial
statements and schedule of Midway Airlines Corporation and subsidiary included
in the Annual Report (Form 10-K) for the year ended December 31, 2000.

                                                /s/ Ernst & Young LLP

Raleigh, North Carolina
April 2, 2001
CERTIFICATION PURSUANT TO SECTION
                          302 OF THE SARBANES OXLEY ACT


I, Jeffrey Ploen, certify that:

1. I have  reviewed  this  quarterly  report on Form 10-QSB of Tonga Capital
Corp.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) designed such disclosure controls and procedures to ensure that material
information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the
period in which this quarterly report is being prepared;

b) evaluated the effectiveness of the registrant's disclosure controls and
procedures as of a date within 90 days prior to the filing date of this
quarterly report (the "Evaluation Date"); and

c) presented in this quarterly report our conclusions about the effectiveness of
the disclosure controls and procedures based on our evaluation as of the
Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent
functions):

a) all significant deficiencies in the design or operation of internal controls
which could adversely affect the registrant's ability to record, process,
summarize and report financial data and have identified for the registrant's
auditors any material weaknesses in internal controls; and

<PAGE>

b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal controls; and

6. The  registrant's  other  certifying  officers  and I have  indicated in this
quarterly report whether there were significant  changes in internal controls or
in other factors that could significantly affect internal controls subsequent to
the date of our most recent  evaluation,  including any corrective  actions with
regard to significant deficiencies and material weaknesses.

Date: August 13, 2004


/s/ Jeffrey Ploen
- -----------------------
 Jeffrey Ploen, CEO and CFO
Exhibit 15.2





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-102288 and 333-92491) pertaining to the Stock Option plans of Ellomay Capital Ltd. and on Form F-3 (File Nos. 333-144171, 333-115826, 333-114428, 333-47842 and 333-92493) of Ellomay Capital Ltd. and in the related Prospectuses of our report dated April 14, 2011, with respect to the consolidated financial statements of Ellomay Capital Ltd. and its subsidiaries included in this Annual Report on Form 20-F for the year ended December 31, 2011.





Tel Aviv, Israel

April 5, 2012
/s/ Kost Forer Gabbay & Kasierer

KOST FORER GABBAY & KASIERER

A Member of Ernst & Young Global
----

----

| Name of Subsidiary                      |   | Percentage of Ownership |   | Jurisdiction of Incorporation |
|-----------------------------------------|--------|-------------------------|--------|-------------------------------|
| Ellomay Clean Energy Ltd.               |   | 100%                    |   | Israel                        |
| Ellomay Clean Energy LP                 |   | 100%                    |   | Israel                        |
| Ellomay Luxemburg Holdings S.àr.l. |   | 100%                    |   | Luxemburg                     |
| Ellomay PV One S.r.l.                   |   | 100%1                   |   | Italy                         |
| Ellomay PV Two S.r.l.                   |   | 100%1                   |   | Italy                         |
| Ellomay PV Five S.r.l.                  |   | 100%1                   |   | Italy                         |
| Ellomay PV Six S.r.l.                   |   | 100%1                   |   | Italy                         |
| Energy Resources Galatina S.r.l.        |   | 100%1                   |   | Italy                         |
| Pedale S.r.l.                           |   | 100%1                   |   | Italy                         |
| Luma Solar S.r.l.                       |   | 100%1                   |   | Italy                         |
| Murgia Solar S.r.l.                     |   | 100%1                   |   | Italy                         |

----

----
# L_2021204DE.01005201.xml

| 10.6.2021 | DE | Amtsblatt der Europäischen Union | L 204/52 |
| --- | --- | --- | --- |

10.6.2021

DE

Amtsblatt der Europäischen Union

L 204/52

---

Berichtigung der Verordnung (EU) 2018/1119 der Kommission vom 31. Juli 2018 zur Änderung der Verordnung (EU) Nr. 1178/2011 im Hinblick auf erklärte Ausbildungsorganisationen

(
  Amtsblatt der Europäischen Union L 204 vom 13. August 2018
  )

Seite 20, Anhang II zur Änderung von Anhang VI der Verordnung (EU) Nr. 1178/2011 (Teil-ARA) Ziffer 5, Einfügung von Buchstabe f in Punkt ARA.GEN.305, Satz 2:

Anstatt:

„Die Aufsichtstätigkeiten umfassen — auch unangekündigte — Inspektionen und können, wenn es die zuständige Behörde für notwendig erachtet, auch Rechnungsprüfungen beinhalten.“

muss es heißen:

„Die Aufsichtstätigkeiten umfassen — auch unangekündigte — Inspektionen und können, wenn es die zuständige Behörde für notwendig erachtet, auch Audits beinhalten.“

---
**EXHIBIT 99.2**

**CERTIFICATION OF PERIODIC REPORT**

I, Kenneth W. Sanders, Chief Financial Officer of SportsLine.com, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

| (3)    |   | the Annual Report on Form 10-K of the Company for the annual period ended December 31, 2002 (the “Report”) fully complies with the requirements of Section 13(a) or15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and |
|--------|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                     |
| (4)    |   | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.                                                                                                     |

Dated:  March 28, 2003

|   | /s/K ENNETH W. SANDERS                         |
|--------|------------------------------------------------|
|   |                                                |
|   | **Kenneth W. Sanders Chief Financial Officer** |
# C_2014102EN.01001902.xml

| 7.4.2014 | EN | Official Journal of the European Union | C 102/19 |
| --- | --- | --- | --- |

7.4.2014

EN

Official Journal of the European Union

C 102/19

---

Request for a preliminary ruling from the Cour de cassation (France) lodged on 27 January 2014 — Directeur général des douanes et droits indirects, Chef de l’agence de poursuites de la Direction nationale du renseignement et des enquêtes douanières, Directeur régional des douanes et droits indirects de Lyon v Utopia SARL, operating under the business name Marshall Bioresources

(Case C-40/14)

2014/C 102/27

Language of the case: French

Referring court

Referring court

Cour de cassation

Parties to the main proceedings

Parties to the main proceedings

Applicants: Directeur général des douanes et droits indirects, Chef de l’agence de poursuites de la Direction nationale du renseignement et des enquêtes douanières, Directeur régional des douanes et droits indirects de Lyon

Applicants:

Defendant: Utopia SARL, operating under the business name Marshall Bioresources

Defendant:

Questions referred

Questions referred

| 1. | Is an importer of animals specially prepared for laboratory use entitled to the relief from import duties provided for for goods of this type by Article 60 of Council Regulation (EEC) No 918/83 of 28 March 1983 setting up a Community system of reliefs from customs duty (1) when it is not itself a public establishment or an authorised private establishment which is principally engaged in education or scientific research, but its clients are establishments meeting those conditions? |
| --- | --- |

1.

Is an importer of animals specially prepared for laboratory use entitled to the relief from import duties provided for for goods of this type by Article 60 of Council Regulation (EEC) No 918/83 of 28 March 1983 setting up a Community system of reliefs from customs duty (1) when it is not itself a public establishment or an authorised private establishment which is principally engaged in education or scientific research, but its clients are establishments meeting those conditions?

1

| 2. | Must Rule 5(b) of the General Rules for the interpretation of the combined nomenclature be interpreted as meaning that cages used for transportation of live animals intended for laboratory research should be categorised as packing materials or packing containers for the purposes of that rule?
  If so, must the words ‘clearly suitable for repetitive use’ in relation to such packing materials or packing containers be assessed in general or only in respect of re-use within the Union? |
| --- | --- |

2.

Must Rule 5(b) of the General Rules for the interpretation of the combined nomenclature be interpreted as meaning that cages used for transportation of live animals intended for laboratory research should be categorised as packing materials or packing containers for the purposes of that rule?

If so, must the words ‘clearly suitable for repetitive use’ in relation to such packing materials or packing containers be assessed in general or only in respect of re-use within the Union?

---

(1)  OJ L 1983 105, p. 1.

1

---
§ 522.2343 Testosterone propionate and estradiol benzoate. ( a ) *Sponsors.* See sponsors in § 510.600(c) of this chapter for use as in paragraph (d) of this section. ( 1 ) No. 054771 for use as in paragraph (d)(1) of this section.
( 2 ) No. 058198 for use as in paragraph (d)(2) of this section.
( b ) *Related tolerances.* See §§ 556.240 and 556.710 of this chapter.
( c ) *Special considerations.* Labeling of the implants described in paragraph (d)(2) of this section shall bear the following: “Federal law restricts this drug to use by or on the order of a licensed veterinarian.”
( d ) *Conditions of use* — ( 1 ) *Growing beef heifers fed in confinement for slaughter* — ( i ) *Amounts and indications for use.* An implant containing 200 mg testosterone propionate and 20 mg estradiol benzoate (one implant consisting of eight pellets, each containing 25 mg testosterone propionate and 2.5 mg estradiol benzoate) for increased rate of weight gain and improved feed efficiency.
( ii ) *Limitations.* Implant pellets subcutaneously in ear only. Not approved for repeated implantation (reimplantation) with this or any other cattle ear implant. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because safety and effectiveness have not been evaluated. Do not use in dairy cows or in animals intended for subsequent breeding. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.
( 2 ) *Growing beef heifers weighing 400 lbs or more* — ( i ) *Amounts and indications for use.* An implant containing 200 mg testosterone propionate, 20 mg estradiol benzoate, and 29 mg tylosin tartrate (one implant consisting of eight pellets, each containing 25 mg testosterone propionate and 2.5 mg estradiol benzoate, and one pellet containing 29 mg tylosin tartrate) for increased rate of weight gain and improved feed efficiency.
( ii ) *Limitations.* Implant pellets subcutaneously in ear only. Not approved for repeated implantation (reimplantation) with this or any other cattle ear implant. Do not use in beef calves less than 2 months of age, dairy calves, and veal calves because safety and effectiveness have not been evaluated. Do not use in dairy cows or in animals intended for subsequent breeding. Use in these cattle may cause drug residues in milk and/or in calves born to these cows.
[89 FR 42358, May 15, 2024]
§ 422.7 Notification of ARIO during an inquiry or investigation. ( a ) Research institutions that conduct USDA-funded extramural research must promptly notify the ARIO should the institution become aware during an inquiry or investigation that: ( 1 ) Public health or safety is at risk;
( 2 ) The resources, reputation, or other interests of USDA are in need of protection;
( 3 ) Research activities should be suspended;
( 4 ) Federal action may be needed to protect the interest of a subject of the investigation or of others potentially affected;
( 5 ) A premature public disclosure of the inquiry into or investigation of the allegation may compromise the process;
( 6 ) The scientific community or the public should be informed; or
( 7 ) There is reasonable indication of possible violations of civil or criminal law.
( b ) If research misconduct proceedings reveal behavior that may be criminal in nature at any point during the proceedings, the institution must promptly notify the ARIO.
EXHIBIT 32.1

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the quarter ended March 31, 2009 of Crimson Exploration Inc. (the “Issuer”).  The undersigned hereby certifies that the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer. 

 

| Date:

  | May 15, 2009

                   |   |
|---------------|---------------------------------------|--------|
|          | /s/ Allan D. Keel                     |   |
| Name:         | Allan D. Keel                         |   |
| Title:        | President and Chief Executive Officer |   |
|          |                                  |   |
|          |                                  |   |

 

A signed original of this written statement required by Section 906 has been provided to the Issuer and will be furnished to the Securities and Exchange Commission, or its staff, upon request.